Market research

CELL PhenomeX Inc.

NASDAQ USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 99M
P/E ratio: Not available
Analyst target: 1
Dividend yield: 0.0%
Beta: 0.94

Loading price history…

Profile

Company facts

Exchange: NASDAQ
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: US0843101017
Market cap: 99M
P/E ratio: Not available
Analyst target: 1
Dividend yield: 0.0%
Beta: 0.94

About

About PhenomeX Inc.

PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease. The company's platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. PhenomeX Inc. is headquartered in Emeryville, California. As of September 29, 2023, PhenomeX Inc. operates as a subsidiary of Bruker Corporation.

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about CELL.

CELL PhenomeX Inc.

Price & volume

Company facts

About PhenomeX Inc.

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet